Rayner's Recently Acquired Ophteis OVD Range and What This Means for Cataract Surgery
Professor Steve Arshinoff and Rayner CEO Tim Clover announce Rayner's recent acquisition of the Ophteis OVD range at the Company's celebratory event, held at the 2015 ESCRS in Barcelona.
Professor Steve Arshinoff and
For further information on the
Back to the
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.